(Q51207374)

1 April 2018

reason for preferred rank

title

Pathophysiology, clinical manifestations and therapy of consumption-coagulopathy (“Verbrauchskoagulopathie”) (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

26 July 2023

Pathophysiology, clinical manifestations and therapy of consumption-coagulopathy ("Verbrauchskoagulopathie") (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6038718

26 July 2023

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

26 July 2023

author name string

H. G. Lasch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6038718

26 July 2023

D. L. Heene

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6038718

26 July 2023

K. Huth

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6038718

26 July 2023

W. Sandritter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6038718

26 July 2023

language of work or name

English

0 references

publication date

1 September 1967

1 reference

1 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0002914967900628?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

https://api.elsevier.com/content/article/PII:0002914967900628?httpAccept=text/plain

26 July 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

American Journal of Cardiology

26 July 2023

published in

1 reference

1 April 2018

volume

20

1 reference

1 April 2018

issue

3

1 reference

1 April 2018

page(s)

381-391

1 reference

1 April 2018

[The mechanism of formation of coagulating factors prothrombin and factor VII]

cites work

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

Blood coagulation and the generalized Shwartzman reaction

26 July 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

The role of the reticuloendothelial system in diffuse, low grade intravascular coagulation

26 July 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

Reticuloendothelial clearance of circulating fibrin in the pathogenesis of the generalized Shwartzman reaction

26 July 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

Blood clotting system in the pathogenesis of the Sanarelli-Shwartzman reaction of the rabbit

26 July 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

Vasculokinase, a Clotting Substance from Arteries

26 July 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

The physiological disturbances produced by endotoxins

26 July 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

Endotoxins in traumatic shock

26 July 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

Induced Hypersensitivity to Cold

26 July 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

Shock and disseminated intravascular coagulation

26 July 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products

26 July 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

Diagnosis of diffuse intravascular clotting: its relation to secondary fibrinolysis and treatment with heparin

26 July 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

EXCESSIVE CONSUMPTION OF BLOOD COAGULATION COMPONENTS AS CAUSE OF HEMORRHAGIC DIATHESIS.

26 July 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

Purpura fulminans treated successfully with anticoagulation; report of a case

26 July 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

[Therapy of paroxysmal nocturnal hemoglobinuria]

26 July 2023

49

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

The prevention of the generalized Shwartzman reaction by fibrinolytic activity

26 July 2023

50

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

Prevention of "irreversible" hemorrhagic shock with fibrinolysin

26 July 2023

52

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

The effect of fibrinolysis on the courses of hemorrhagic shock

26 July 2023

53

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

[On thrombolytic therapy of a recent myocardial infarct. I. Introduction, treatment plans, general clinical results]

26 July 2023

54

1 reference

https://api.crossref.org/works/10.1016/0002-9149(67)90062-8

26 July 2023

Identifiers

1 reference

1 April 2018

1 reference

1 April 2018